Next Generation Capecitabine (NGC-Cap) in Phase 1b Trial Significantly Increases 5-FU Exposure While Improving Safety Profile Compared to Capecitabine
Other
April 11, 2024
David Young, Sian Bigora, Mary Nyberg, Kayla Parks, Amit Mahipal, Patrick Boland, Eric J. Feldman, Howard Hochster
View Publication